Maypro Partner, BioActives, LLC, Announces Launch of MicroActive® Astaxanthin

PURCHASE, NY – BioActives, LLC has announced the launch of its latest ingredient MicroActive® Astaxanthin, a sustained-release advanced astaxanthin formulation shown to be 4 times more bioavailable than regular astaxanthin oil.

MicroActive® Astaxanthin is a 10% concentrate and is supported by human and advanced dissolution studies.  The advanced formation will uniformly deliver benefits to more consumers regardless of age, diet, or genetic composition.  The product complements other commercially successfully ingredients formulated in the MicroActive® line, including CoQ10, curcumin, resveratrol, and PQQ.

"We believe that the astaxanthin category is poised to grow and this is ideal timing to bring to market an advanced value-added form if this emerging ingredient" said Dr. Dan Kagan PhD, a partner of BioActives.

BioActives has appointed Maypro Industries as the exclusive distributor for the ingredient.  "We are very pleased to further expand our successful partnership with BioActives" said Dan Lifton, President of Maypro's Proprietary Branded Ingredients division.  "We want to build on our joint success of bringing to market MicroActive® CoQ10, curcumin, resveratrol, and PQQ in the last 5 years."

You can watch a short introductory video on the ingredient at  For an overview on MicroActive® Astaxanthin including a copy of the clinical study and more information on the full line of MicroActive® products, please contact or call 914-251-0701.

*These statements have not been evaluated by the Food & Drug Administration.
These ingredients are not intended to diagnose, treat, cure, or prevent any disease.

About BioActives

A New England-based IP development company that has developed, patented, researched, and commercialized highly innovative advanced formulations of carotenoids, botanical extracts, and specialty ingredients, including those based on its proprietary MicroActive® technology. BioActives develops active nutraceutical ingredients and advance encapsulation systems that promote improved bioavailability, sustained release, and uniform absorption. Development includes bench-top formulation, absorption simulations, human trials and scaled-up commercial processes. For more information, please visit

About Maypro

Headquartered in Purchase, NY and with offices in Tokyo and Shanghai, Maypro Group is a leading global supplier of specialty nutraceutical ingredients to the nutritional supplement, sports nutrition, pet and veterinary, cosmetic, functional food and fine chemical industries.  In addition to being a leading supplier of mainstream products such as CoQ10, fish oil, glucosamine and various botanical extracts, Maypro also markets a very strong portfolio of clinically validated proprietary and branded ingredients, representing some of the top manufacturers from Japan, Europe, and the United States.  For more information, please visit